Turing Pharmaceutical's CEO has backed down on the 4000% price hike for Daraprim, but is the damage done? Take our poll.
You’ve read about Turing Pharmaceuticals’ recent attempt to increase the cost of Daraprim by about 4000%.
Do you think this move is:
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.